Subscribe To
Arcturus therapeutics holdings inc. (arct) ceo joseph payne on q1 2022 results - earnings call transcript
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT ) Q1 2022 Results Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Deepankar Roy ...
May 9, 2022, 11:09 pm
Caladrius biosciences, inc. (clbs) ceo david mazzo on q1 2022 results - earnings call transcript
Caladrius Biosciences, Inc. (NASDAQ:CLBS ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants John Menditto - VP, Investor R...
May 5, 2022, 11:29 pm
Blackline, inc. (bl) ceo marc huffman on q1 2022 results - earnings call transcript
Blackline, Inc. (NASDAQ:BL ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participan...
May 5, 2022, 11:20 pm
Springworks therapeutics: rating buy ahead of mid-year data releases
Data from Phase 3 trial for Nirogacestat in treating desmoid tumors and Phase 2 combination trial with anti-BCMA antibody Blenrep in relapsed/refracto...
May 2, 2022, 5:42 pm
Brookline bancorp inc. (brkl) ceo paul perrault on q1 2022 results - earnings call transcript
Brookline Bancorp Inc. (NASDAQ:BRKL ) Q1 2022 Earnings Conference Call April 28, 2022 1:30 PM ET Compan...
April 29, 2022, 7:53 am
Glaxosmithkline shares look at five-year highs as activists go quiet
GlaxoSmithkline shares edged towards their best for five years after what analysts said was an impressi...
April 27, 2022, 9:03 am
Glaxosmithkline beats expectations boosted by covid-19 treatment. the stock is up.
The British drugmaker's antibody treatment for Covid-19 generated sales of £1.3 billion during the quarter....
April 27, 2022, 4:55 am
Glaxosmithkline sales bounce higher after covid boost
GlaxoSmithkline has confirmed its total dividend this year will be cut by 35% following the demerger of...
April 27, 2022, 3:22 am
Glaxosmithkline earnings, revenue beat expectations
GlaxoSmithkline PLC on Wednesday posted higher earnings and revenue for the first quarter, beating expe...
April 27, 2022, 3:11 am
Glaxosmithkline new drug application for specialist anaemia treatment
A week after announcing plans to boost its late-stage pipeline with the £1.5bn acquisition of Sierra Oncology (NASDAQ:SRRA), GlaxoSmith...
April 19, 2022, 3:25 am
Late-stage biopharmaceutical sierra oncology announces acquisition by gsk
Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmith...
April 13, 2022, 1:49 pm
Why is sierra oncology (srra) stock up today?
Late-phase cancer treatment company Sierra Oncology is up big today after being acquired by GlaxoSmithkline...
April 13, 2022, 11:42 am
Sierra oncology stock is soaring: here's why
Sierra Oncology Inc (NASDAQ: SRRA) shares are trading significantly higher Wednesday after the company announced it will be acquired by GlaxoSmith
April 13, 2022, 11:20 am
Sierra oncology soars after takeover by glaxo
The deal comes ahead of GlaxoSmithkline's planned spinoff of its consumer health division in July....
April 13, 2022, 8:19 am
Glaxosmithkline scoops up rare cancer-focused sierra oncology in $1.9b cash deal
GlaxoSmithkline plc (NYSE: GSK) has agreed to acquire Sierra Oncology Inc (NASDAQ: SRRA) for $55 per...
April 13, 2022, 8:08 am
Why glaxosmithkline (gsk) is buying sierra oncology (srra) for $1.9 billion
GlaxoSmithkline plc (NYSE: GSK) announced it is buying Sierra Oncology, Inc (Nasdaq: SRRA) for $1.9 bil...
April 13, 2022, 8:06 am
Glaxosmithkline to buy sierra oncology for $1.9 billion
Pharmaceutical giant GlaxoSmithkline PLC said Wednesday that it is buying biopharmaceutical company Sie...
April 13, 2022, 2:36 am
Glaxosmithkline boosts its oncology product line as it swoops for american drug developer in us$1.9bn deal
It is the fate of the small(er) drug developer – to be taken out just when all the hard yards have been put in. And it's exactly what's happened to ...
April 13, 2022, 2:33 am
Gsk to buy sierra oncology for $1.9 billion
Britain's GlaxoSmithkline has agreed to buy California-based biopharmaceutical company Sierra Oncology ...
April 13, 2022, 2:23 am
Curevac, gsk ink 'pandemic preparedness' agreement through 2029 with german government
Shares of CureVac CVAC, -0.28% were up 0.6% in premarket trading on Monday after the company and GlaxoSmithkli...
April 11, 2022, 8:01 am